These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 32847092)

  • 1. Health Technology Assessment Report on Vagus Nerve Stimulation in Drug-Resistant Epilepsy.
    Marras CE; Colicchio G; De Palma L; De Benedictis A; Di Gennaro G; Cavaliere M; Cesaroni E; Consales A; Asioli S; Caulo M; Villani F; Zamponi N
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32847092
    [No Abstract]   [Full Text] [Related]  

  • 2. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
    Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
    J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
    Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
    J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy.
    Purser MF; Mladsi DM; Beckman A; Barion F; Forsey J
    Adv Ther; 2018 Oct; 35(10):1686-1696. PubMed ID: 30143957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children.
    Orosz I; McCormick D; Zamponi N; Varadkar S; Feucht M; Parain D; Griens R; Vallée L; Boon P; Rittey C; Jayewardene AK; Bunker M; Arzimanoglou A; Lagae L
    Epilepsia; 2014 Oct; 55(10):1576-84. PubMed ID: 25231724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy.
    Helmers SL; Duh MS; Guérin A; Sarda SP; Samuelson TM; Bunker MT; Olin BD; Jackson SD; Faught E
    Eur J Paediatr Neurol; 2012 Sep; 16(5):449-58. PubMed ID: 22261080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality-of-life metrics with vagus nerve stimulation for epilepsy from provider survey data.
    Englot DJ; Hassnain KH; Rolston JD; Harward SC; Sinha SR; Haglund MM
    Epilepsy Behav; 2017 Jan; 66():4-9. PubMed ID: 27974275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Technology Assessment report on the presurgical evaluation and surgical treatment of drug-resistant epilepsy.
    Marras CE; Canevini MP; Colicchio G; Guerrini R; Rubboli G; Scerrati M; Spreafico R; Tassi L; LoRusso G; Tinuper P;
    Epilepsia; 2013 Oct; 54 Suppl 7():49-58. PubMed ID: 24099055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre- and postoperative heart rate variability and vagus nerve stimulation in patients with drug-resistant epilepsy - A meta-analysis.
    Wu ML; Hu DM; Wang JJ; Liu XL; Liu L; Li Y; Jing W
    Epilepsy Behav; 2021 Oct; 123():108247. PubMed ID: 34418640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of vagus nerve stimulation therapy after failed epilepsy surgery.
    Vale FL; Ahmadian A; Youssef AS; Tatum WO; Benbadis SR
    Seizure; 2011 Apr; 20(3):244-8. PubMed ID: 21196125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of vagus nerve stimulation for drug-resistant epilepsy: the first three years of a prospective Japanese registry.
    Kawai K; Tanaka T; Baba H; Bunker M; Ikeda A; Inoue Y; Kameyama S; Kaneko S; Kato A; Nozawa T; Maruoka E; Osawa M; Otsuki T; Tsuji S; Watanabe E; Yamamoto T
    Epileptic Disord; 2017 Sep; 19(3):327-338. PubMed ID: 28832004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of quality of life (QOL) in patients with epilepsy and comorbid psychogenic nonepileptic seizures (PNES) after vagus nerve stimulation (VNS).
    Vivas AC; Reitano CJ; Waseem H; Benbadis SR; Vale FL
    Epilepsy Behav; 2017 Aug; 73():208-213. PubMed ID: 28651170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term seizure and psychosocial outcomes of vagus nerve stimulation for intractable epilepsy.
    Wasade VS; Schultz L; Mohanarangan K; Gaddam A; Schwalb JM; Spanaki-Varelas M
    Epilepsy Behav; 2015 Dec; 53():31-6. PubMed ID: 26515157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of vagus nerve stimulation on secondary care burden in children and adults with epilepsy: Review of routinely collected hospital data in England.
    Camp C; Smithson WH; Bunker M; Burke T; Hughes D
    Epilepsy Behav; 2015 Nov; 52(Pt A):68-73. PubMed ID: 26409132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory epilepsy in tuberous sclerosis: vagus nerve stimulation with or without subsequent resective surgery.
    Elliott RE; Carlson C; Kalhorn SP; Moshel YA; Weiner HL; Devinsky O; Doyle WK
    Epilepsy Behav; 2009 Nov; 16(3):454-60. PubMed ID: 19767244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of pharmacotherapy regimen and costs in patients with drug-resistant epilepsy following vagus nerve stimulation therapy: a single-center study (Poland).
    Kopciuch D; Barciszewska AM; Fliciński J; Zaprutko T; Kus K; Steinborn B; Nowakowska E
    Acta Neurol Belg; 2020 Feb; 120(1):115-122. PubMed ID: 31721076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of the ketogenic diet and vagus nerve stimulation for the treatment of children with intractable epilepsy.
    de Kinderen RJ; Postulart D; Aldenkamp AP; Evers SM; Lambrechts DA; Louw AJ; Majoie MH; Grutters JP
    Epilepsy Res; 2015 Feb; 110():119-31. PubMed ID: 25616464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review.
    Assenza G; Tombini M; Lanzone J; Ricci L; Di Lazzaro V; Casciato S; Morano A; Giallonardo AT; Di Bonaventura C; Beghi E; Ferlazzo E; Gasparini S; Giuliano L; Pisani F; Benna P; Bisulli F; De Falco FA; Franceschetti S; La Neve A; Meletti S; Mostacci B; Sartucci F; Striano P; Villani F; Aguglia U; Avanzini G; Belcastro V; Bianchi A; Cianci V; Labate A; Magaudda A; Michelucci R; Verri A; Zaccara G; Pizza V; Tinuper P; Di Gennaro G;
    Neurol Sci; 2020 Nov; 41(11):3075-3084. PubMed ID: 32524324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic and clinical evaluation of vagus nerve stimulation therapy.
    Kopciuch D; Barciszewska AM; Fliciński J; Paczkowska A; Winczewska-Wiktor A; Jankowski R; Steinborn B; Nowakowska E
    Acta Neurol Scand; 2019 Oct; 140(4):244-251. PubMed ID: 31165476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcutaneous auricular vagus nerve stimulation for pediatric epilepsy: study protocol for a randomized controlled trial.
    He W; Wang XY; Zhou L; Li ZM; Jing XH; Lv ZL; Zhao YF; Shi H; Hu L; Su YS; Zhu B
    Trials; 2015 Aug; 16():371. PubMed ID: 26292720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.